Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
InChi: InChI=1S/C21H16FN3OS
is an orally bioavailable inhibitor of histone deacetylases (HDACs) with potential antineoplastic activity
24)/b19-11+
130663-39-7
attenuated footshock stress-induced eLAC elevation in the mPFC
Vaniprevir - CAS# 923590-37-8 Size:Solid 10 mg InChi: InChI=1S/C21H16FN3OSVaniprevir, also known as MK7009, is a macrocyclic hepatitis C virus (HCV) NS3 4a protease inhibitor. Vaniprevir is active against both the genotype 1 and genotype 2 NS3 4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species. Vaniprevir is a potent HCV protease inhibitor with a predictable resistance profile and favorable safety profile that is suitable for QD or BID administration. In Japan, it was approved
US$ 1749.50
US$ 1749.50
US$ 125.00
US$ 2099.50